ME01631B - Medicinski aerosolni proizvodi - Google Patents

Medicinski aerosolni proizvodi

Info

Publication number
ME01631B
ME01631B MEP-1999-598A MEP1999598A ME01631B ME 01631 B ME01631 B ME 01631B ME P1999598 A MEP1999598 A ME P1999598A ME 01631 B ME01631 B ME 01631B
Authority
ME
Montenegro
Prior art keywords
ciclesonide
hydrofluorocarbon
hfc
propellants
surfactants
Prior art date
Application number
MEP-1999-598A
Other languages
German (de)
English (en)
French (fr)
Inventor
Martin J Oliver
Kanu M Fatania
John S Scott
Helgert Muller
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710496.2A external-priority patent/GB9710496D0/en
Priority claimed from GBGB9803990.2A external-priority patent/GB9803990D0/en
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of ME01631B publication Critical patent/ME01631B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

            Farmaceutska aerosolskaformulacija, pogodna za oralnu i/ili nazalnu inhalaciju, koja sadržiantiinflamatorni lek ciklezonid, fluorougljovodonične 5propelente kao što su HFC 134a i/ili 227, i etanol u količini dovoljnojda se rastvori ciklezonid (i, u datom slučaju,različite sastojke,kao što su površinski aktivne supstance). Formulacije ispoljavaju veomapoželjnu: fizičku i hemijsku stabilnost, kao i odlične karaktiristikeu doziranju.              Farmaceutska aerosolskaformulacija, pogodna za oralnu i/ili nazalnu inhalaciju, koja sadržiantiinflamatorni lek ciklezonid, fluorougljovodonične 5propelente kao što su HFC 134a i/ili 227, i etanol u količini dovoljnojda se rastvori ciklezonid (i, u datom slučaju,različite sastojke,kao što su površinski aktivne supstance). Formulacije ispoljavaju veomapoželjnu : fizičku i hemijsku stabilnost, kao i odlične karaktiristikeu doziranju.
MEP-1999-598A 1997-05-21 1998-05-18 Medicinski aerosolni proizvodi ME01631B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710496.2A GB9710496D0 (en) 1997-05-21 1997-05-21 Medicinal aerosol products
GBGB9803990.2A GB9803990D0 (en) 1998-02-25 1998-02-25 Medicinal aerosol products
PCT/US1998/010155 WO1998052542A1 (en) 1997-05-21 1998-05-18 Medicinal aerosol products

Publications (1)

Publication Number Publication Date
ME01631B true ME01631B (me) 2007-08-03

Family

ID=26311564

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-1999-598A ME01631B (me) 1997-05-21 1998-05-18 Medicinski aerosolni proizvodi

Country Status (28)

Country Link
US (1) US6120752A (me)
EP (1) EP0983058B1 (me)
JP (4) JP2001526685A (me)
KR (1) KR100527643B1 (me)
CN (1) CN1149073C (me)
AT (1) ATE245966T1 (me)
AU (1) AU726835B2 (me)
BG (1) BG64268B1 (me)
BR (1) BR9809448A (me)
CA (1) CA2290521C (me)
CZ (1) CZ298253B6 (me)
DE (1) DE69816811T2 (me)
DK (1) DK0983058T3 (me)
EA (1) EA002381B1 (me)
ES (1) ES2205491T3 (me)
HK (1) HK1027027A1 (me)
HU (1) HU226694B1 (me)
IL (1) IL132738A (me)
ME (1) ME01631B (me)
NO (2) NO327716B1 (me)
NZ (1) NZ500874A (me)
PL (1) PL191523B1 (me)
PT (1) PT983058E (me)
RS (1) RS49628B (me)
SK (1) SK283930B6 (me)
TR (1) TR199902863T2 (me)
UA (1) UA58551C2 (me)
WO (1) WO1998052542A1 (me)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
WO2004033478A2 (en) * 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
DK3170880T3 (da) * 2002-10-25 2020-07-06 Honeywell Int Inc Anvendelse af sammensætninger, der omfatter hfo-1234ze eller hfo-1234yf som kølemiddelsammensætning
DK1572217T3 (da) * 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
WO2004103379A1 (en) * 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination
WO2004110460A1 (en) * 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
ES2452691T5 (es) * 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
GB2406283B (en) 2003-09-24 2006-04-05 Altana Pharma Ag Compliance monitor and method
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005065185A2 (en) * 2003-12-24 2005-07-21 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
JP2008512428A (ja) * 2004-09-10 2008-04-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング シクレソニドとＳｙｋインヒビターとの組合せ物並びにその使用方法
JP2008546634A (ja) * 2005-03-16 2008-12-25 ハネウェル・インターナショナル・インコーポレーテッド 医薬送達製剤、デバイス及び方法
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
CN102348714B (zh) * 2009-03-09 2015-01-07 三笠制药株式会社 甾族化合物
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
MX2013004137A (es) * 2010-10-12 2013-07-29 Cipla Ltd Composicion farmaceutica.
AU2012296880A1 (en) 2011-08-18 2014-03-27 Astrazeneca Ab Pharmaceutical aerosol product for administration by oral or nasal inhalation
CN102335132A (zh) * 2011-10-12 2012-02-01 中山大学 一种细辛脑吸入气雾剂及其制备方法
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077229B (en) * 1980-05-16 1983-08-03 Neotechnic Eng Ltd Valve assembly for a pressurized aerosoldispensing container
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
WO1991014422A1 (en) * 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
DE69105212T2 (de) * 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
DK0735884T3 (da) * 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
KR19980703850A (ko) * 1995-04-14 1998-12-05 그레이엄브레레톤 베클로메타손 디프로피오네이트용 계량 흡입기
EP0820323B1 (en) * 1995-04-14 2003-09-24 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
SI0820279T1 (en) * 1995-04-14 2002-12-31 Smithkline Beecham Corporation Metered dose inhaler for albuterol

Also Published As

Publication number Publication date
PL336885A1 (en) 2000-07-17
CZ298253B6 (cs) 2007-08-08
EP0983058B1 (en) 2003-07-30
DK0983058T3 (da) 2003-11-24
NO995667L (no) 1999-11-18
UA58551C2 (uk) 2003-08-15
HU226694B1 (en) 2009-06-29
CA2290521A1 (en) 1998-11-26
EP0983058A1 (en) 2000-03-08
NO995667D0 (no) 1999-11-18
JP6087882B2 (ja) 2017-03-01
PL191523B1 (pl) 2006-06-30
IL132738A (en) 2004-06-20
TR199902863T2 (xx) 2000-05-22
CA2290521C (en) 2006-10-10
JP2016169222A (ja) 2016-09-23
YU59899A (sh) 2002-06-19
JP2011102301A (ja) 2011-05-26
AU7496298A (en) 1998-12-11
EA002381B1 (ru) 2002-04-25
KR20010012810A (ko) 2001-02-26
NO2009024I1 (no) 2009-10-26
AU726835B2 (en) 2000-11-23
NO327716B1 (no) 2009-09-14
JP2001526685A (ja) 2001-12-18
ATE245966T1 (de) 2003-08-15
CN1257421A (zh) 2000-06-21
SK283930B6 (sk) 2004-05-04
US6120752A (en) 2000-09-19
BG103902A (en) 2000-05-31
RS49628B (sr) 2007-08-03
NO2009024I2 (no) 2010-08-16
HUP0002691A2 (hu) 2001-02-28
IL132738A0 (en) 2001-03-19
SK157699A3 (en) 2000-05-16
JP6178459B2 (ja) 2017-08-09
HUP0002691A3 (en) 2001-04-28
KR100527643B1 (ko) 2005-11-15
ES2205491T3 (es) 2004-05-01
BR9809448A (pt) 2000-06-20
DE69816811T2 (de) 2004-04-15
JP2015024999A (ja) 2015-02-05
NZ500874A (en) 2001-09-28
PT983058E (pt) 2003-12-31
CN1149073C (zh) 2004-05-12
HK1027027A1 (en) 2001-01-05
WO1998052542A1 (en) 1998-11-26
DE69816811D1 (de) 2003-09-04
CZ412499A3 (cs) 2000-02-16
BG64268B1 (bg) 2004-08-31
EA199900991A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
ME01631B (me) Medicinski aerosolni proizvodi
DK0553298T3 (da) Aerosolformulering omfattende beclomethason-17,21-dipropionat
RS49803B (sr) Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa
ES2158911T3 (es) Formulaciones en aerosol sin clorofluorocarbonos.
ES2174970T3 (es) Mezcla propelente para formulacion de aerosol.
ATE398999T1 (de) Aerosol-formulierungen von formoterol und mometason
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
PT1037604E (pt) Composicoes farmaceuticas de aerossol
AR019853A1 (es) Derivado del acido 3-aril-2-hidroxipropionico, proceso e intermediario para su preparacion, formulaciones farmaceuticas, uso de dicho compuesto en laelaboracion de un medicamento, metodo para la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina, y formulaci
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
NO20030897L (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
CL2004001325A1 (es) Una composicion farmaceutica de aerosol que comprende cilesonida solubilizada en un propelente hidrofluorocarbono y un co-solvente, de preferencia etanol, util como antiinflamatorio de las vias aereas.
ZA968762B (en) Derivatives of acid pyrazoles, their preparation process, their use as medicaments, their new use and the pharmaceutical compositions containing them.
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
TR200301552A1 (tr) Rofekoksib' in yeni oral farmakolojik formülasyonları.
TH167213A (th) อนุพันธ์ ไธอะโซลิล เอไมด์ (Thiazolyl amide derivatives )
TH29519B (th) สูตรผสมทางเภสัชศาสตร์ที่เสถียรชนิดใหม่สำหรับการผลิตละอองลอยที่ไม่มีแก๊สผลักดัน